Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2014

The NitiLoop/NovaCross Technology to Facilitate CTO Recanalization

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Ran Kornowski

September 16, 2014

Presentation TCT 2014

TCT 310: Recanalization Of Chronic Total Coronary Occlusions: The Influence on Collateral Donor Artery Physiology and Fractional Flow Reserve

Presenter: William F. Fearon, Bon-Kwon Koo, Michael J. Lim, Andrew Ladwiniec

September 14, 2014

Presentation TCT 2014

Case #2: Recanalization of a CTO with Reentry at a Bifurcation

Presenter: Sorin J. Brener, Walter Desmet, Claude Hanet, Jose P.S. Henriques, René J. van der Schaaf, Vincent Segers

September 14, 2014

Presentation TCT 2014

TCT 191: Health-Related Quality of Life, Functional Status, and Myocardial Ischemia in Patients with Successful Chronic Total Occlusion Recanalization

Presenter: David E. Kandzari, Maarten J. Suttorp, Richard R. Heuser, Ester Bajo

September 13, 2014

Presentation TCT 2014

Case #4: CTO Retrograde Recanalization Guided by IVUS

Presenter: Andrea Abizaid, Kurt Huber, Bela Merkely, Peter Hausinger

September 13, 2014

Presentation TCT 2013

The Evidence for CTO Recanalization: Establishing the Indications

Presenter: Ran Kornowski

October 31, 2013

Presentation TCT 2013

The Essential Technique of CTO Recanalization: Algorithm and Approach

Presenter: J. Aaron Grantham

October 31, 2013

Presentation TCT 2013

Advanced Interventional Approaches: When Is CTO Recanalization Justified in MVD?

Presenter: Barry Rutherford

October 29, 2013

Presentation TCT 2012

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Presenter: Hiroyuki Tanaka

October 23, 2012

Presentation TCT 2012

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

Presenter: John Laird Jr

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Advertisement

The NitiLoop/NovaCross Technology to Facilitate CTO Recanalization

TCT 310: Recanalization Of Chronic Total Coronary Occlusions: The Influence on Collateral Donor Artery Physiology and Fractional Flow Reserve

Case #2: Recanalization of a CTO with Reentry at a Bifurcation

TCT 191: Health-Related Quality of Life, Functional Status, and Myocardial Ischemia in Patients with Successful Chronic Total Occlusion Recanalization

Case #4: CTO Retrograde Recanalization Guided by IVUS

The Evidence for CTO Recanalization: Establishing the Indications

The Essential Technique of CTO Recanalization: Algorithm and Approach

Advanced Interventional Approaches: When Is CTO Recanalization Justified in MVD?

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content